502 related articles for article (PubMed ID: 25755250)
1. SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth.
Yang H; Zhou L; Shi Q; Zhao Y; Lin H; Zhang M; Zhao S; Yang Y; Ling ZQ; Guan KL; Xiong Y; Ye D
EMBO J; 2015 Apr; 34(8):1110-25. PubMed ID: 25755250
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-CoA from inflammation-induced fatty acids oxidation promotes hepatic malate-aspartate shuttle activity and glycolysis.
Wang T; Yao W; Li J; He Q; Shao Y; Huang F
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E496-E510. PubMed ID: 29763372
[TBL] [Abstract][Full Text] [Related]
3. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context.
Kerk SA; Lin L; Myers AL; Sutton DJ; Andren A; Sajjakulnukit P; Zhang L; Zhang Y; Jiménez JA; Nelson BS; Chen B; Robinson A; Thurston G; Kemp SB; Steele NG; Hoffman MT; Wen HJ; Long D; Ackenhusen SE; Ramos J; Gao X; Nwosu ZC; Galban S; Halbrook CJ; Lombard DB; Piwnica-Worms DR; Ying H; Pasca di Magliano M; Crawford HC; Shah YM; Lyssiotis CA
Elife; 2022 Jul; 11():. PubMed ID: 35815941
[TBL] [Abstract][Full Text] [Related]
4. Malate-aspartate shuttle, cytoplasmic NADH redox potential, and energetics in vascular smooth muscle.
Barron JT; Gu L; Parrillo JE
J Mol Cell Cardiol; 1998 Aug; 30(8):1571-9. PubMed ID: 9737943
[TBL] [Abstract][Full Text] [Related]
5. Ischemic Neuroprotectant PKCε Restores Mitochondrial Glutamate Oxaloacetate Transaminase in the Neuronal NADH Shuttle after Ischemic Injury.
Xu J; Khoury N; Jackson CW; Escobar I; Stegelmann SD; Dave KR; Perez-Pinzon MA
Transl Stroke Res; 2020 Jun; 11(3):418-432. PubMed ID: 31473978
[TBL] [Abstract][Full Text] [Related]
6. Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy.
van Karnebeek CDM; Ramos RJ; Wen XY; Tarailo-Graovac M; Gleeson JG; Skrypnyk C; Brand-Arzamendi K; Karbassi F; Issa MY; van der Lee R; Drögemöller BI; Koster J; Rousseau J; Campeau PM; Wang Y; Cao F; Li M; Ruiter J; Ciapaite J; Kluijtmans LAJ; Willemsen MAAP; Jans JJ; Ross CJ; Wintjes LT; Rodenburg RJ; Huigen MCDG; Jia Z; Waterham HR; Wasserman WW; Wanders RJA; Verhoeven-Duif NM; Zaki MS; Wevers RA
Am J Hum Genet; 2019 Sep; 105(3):534-548. PubMed ID: 31422819
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the mitochondrial oxidation of (-)-palmitylcarnitine by the malate-aspartate and alpha-glycerophosphate shuttles.
Lumeng L; Bremer J; Davis EJ
J Biol Chem; 1976 Jan; 251(2):277-84. PubMed ID: 1245472
[TBL] [Abstract][Full Text] [Related]
8. The malate-aspartate shuttle (Borst cycle): How it started and developed into a major metabolic pathway.
Borst P
IUBMB Life; 2020 Nov; 72(11):2241-2259. PubMed ID: 32916028
[TBL] [Abstract][Full Text] [Related]
9. Magnitude of malate-aspartate reduced nicotinamide adenine dinucleotide shuttle activity in intact respiring tumor cells.
Greenhouse WV; Lehninger AL
Cancer Res; 1977 Nov; 37(11):4173-81. PubMed ID: 198130
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria from the left heart ventricles of both normotensive and spontaneously hypertensive rats oxidize externally added NADH mostly via a novel malate/oxaloacetate shuttle as reconstructed in vitro.
Atlante A; Seccia TM; De Bari L; Marra E; Passarella S
Int J Mol Med; 2006 Jul; 18(1):177-86. PubMed ID: 16786170
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of cytosolic NADH by the malate-aspartate shuttle in HuH13 human hepatoma cells.
Matsuno T
Int J Biochem; 1992 Feb; 24(2):313-5. PubMed ID: 1310290
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of the malate-aspartate shuttle in various tumor types.
Greenhouse WV; Lehninger AL
Cancer Res; 1976 Apr; 36(4):1392-6. PubMed ID: 177206
[TBL] [Abstract][Full Text] [Related]
13. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools.
McKenna MC; Waagepetersen HS; Schousboe A; Sonnewald U
Biochem Pharmacol; 2006 Feb; 71(4):399-407. PubMed ID: 16368075
[TBL] [Abstract][Full Text] [Related]
14. Studies on the active transfer of reducing equivalents into mitochondria via the malate-aspartate shuttle.
Bremer J; Davis EJ
Biochim Biophys Acta; 1975 Mar; 376(3):387-97. PubMed ID: 164904
[TBL] [Abstract][Full Text] [Related]
15. Oxidation of reduced cytosolic nicotinamide adenine dinucleotide by the malate-aspartate shuttle in the K-562 human leukemia cell line.
López-Alarcón L; Eboli ML
Cancer Res; 1986 Nov; 46(11):5589-91. PubMed ID: 3756905
[TBL] [Abstract][Full Text] [Related]
16. Regulation of lactate production at the onset of ischaemia is independent of mitochondrial NADH/NAD+: insights from in silico studies.
Zhou L; Stanley WC; Saidel GM; Yu X; Cabrera ME
J Physiol; 2005 Dec; 569(Pt 3):925-37. PubMed ID: 16223766
[TBL] [Abstract][Full Text] [Related]
17. The malate-aspartate shuttle is important for de novo serine biosynthesis.
Broeks MH; Meijer NWF; Westland D; Bosma M; Gerrits J; German HM; Ciapaite J; van Karnebeek CDM; Wanders RJA; Zwartkruis FJT; Verhoeven-Duif NM; Jans JJM
Cell Rep; 2023 Sep; 42(9):113043. PubMed ID: 37647199
[TBL] [Abstract][Full Text] [Related]
18. Inborn disorders of the malate aspartate shuttle.
Broeks MH; van Karnebeek CDM; Wanders RJA; Jans JJM; Verhoeven-Duif NM
J Inherit Metab Dis; 2021 Jul; 44(4):792-808. PubMed ID: 33990986
[TBL] [Abstract][Full Text] [Related]
19. The photorespiratory hydrogen shuttle. Synthesis of phthalonic acid and its use in the characterization of the malate/aspartate shuttle in pea (Pisum sativum) leaf mitochondria.
Dry IB; Dimitriadis E; Ward AD; Wiskich JT
Biochem J; 1987 Aug; 245(3):669-75. PubMed ID: 3663185
[TBL] [Abstract][Full Text] [Related]
20. Bilirubin inhibition of enzymes involved in the mitochondrial malate-aspartate shuttle.
McLoughlin DJ; Howell ML
Biochim Biophys Acta; 1987 Aug; 893(1):7-12. PubMed ID: 3607043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
